这个杂志的目的是提供一个论坛发表相关的临床和实验药理学研究糖尿病、肥胖症和新陈代谢,包括葡萄糖和weight-lowering新药评价新的治疗发展的管理和预防糖尿病并发症,如生长因子为足溃疡和生物技术产品,涉及建立和临床试验药物,如优化治疗高血压,糖尿病人群中的脂质或感染。
This journal aims to provide a forum for publication of clinical and experimental pharmacology studies related to diabetes, obesity and metabolism, including evaluations of new glucose and weight-lowering drugs, new therapeutic developments in the management and prevention of diabetic complications, e.g. growth factors and biotechnology products for foot ulcers, and clinical trials involving established medicines, e.g. optimal treatment of hypertension, lipids or infection in the diabetic population.